UNSPSC 85731015: Revision of autologous tissue substitute in urethra, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in urethra, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TWD77Z

UNSPSC 85731015 Revision of autologous tissue substitute in urethra, via natural or artificial opening, a Commodity code, does not align with the recent state and local contract opportunities posted under this classification. The code nominally describes a surgical procedure for urethral tissue revision, yet the most-recent opportunities reflect medical surveillance, occupational health examinations, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical procedure carve-out benefits, and temporary clinical staffing — none of which concern urethral tissue substitution or related urology procedures. This mismatch indicates either a data coding error in the source records or that the code is not actively used for state and local procurements that match its clinical scope.

The issuing bodies in the posted opportunities span state transportation departments (Washington State Department of Transportation), county human resources and pension functions (City of Phoenix Retirement Office, Collier County Board of County Commissioners), county health systems and probation departments (County of Santa Clara Health System, Harris County Juvenile Probation Department), and municipal employee benefits administration (City of Long Beach). These jurisdictions are soliciting through RFP, RFI, and RFQ vehicles with response dates ranging from September through October 2026, with geographic representation in Arizona, Florida, California, Washington State, and Texas. Given the absence of procurement activity that corresponds to the code's stated clinical scope, this Commodity code shows little actionable recent activity for vendors in urethral reconstruction or autologous tissue substitute services at the state and local level.